PL2662093T3 - Preparat tobramycyny - Google Patents
Preparat tobramycynyInfo
- Publication number
- PL2662093T3 PL2662093T3 PL13002039T PL13002039T PL2662093T3 PL 2662093 T3 PL2662093 T3 PL 2662093T3 PL 13002039 T PL13002039 T PL 13002039T PL 13002039 T PL13002039 T PL 13002039T PL 2662093 T3 PL2662093 T3 PL 2662093T3
- Authority
- PL
- Poland
- Prior art keywords
- tobramycin formulation
- tobramycin
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261644700P | 2012-05-09 | 2012-05-09 | |
| GBGB1208080.0A GB201208080D0 (en) | 2012-05-09 | 2012-05-09 | Tobramycin formulation |
| EP13002039.9A EP2662093B1 (en) | 2012-05-09 | 2013-04-18 | Tobramycin formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2662093T3 true PL2662093T3 (pl) | 2015-06-30 |
Family
ID=46396721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13002039T PL2662093T3 (pl) | 2012-05-09 | 2013-04-18 | Preparat tobramycyny |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9012416B2 (pl) |
| EP (1) | EP2662093B1 (pl) |
| BR (1) | BR112014027708A2 (pl) |
| DK (1) | DK2662093T3 (pl) |
| GB (1) | GB201208080D0 (pl) |
| PL (1) | PL2662093T3 (pl) |
| PT (1) | PT2662093E (pl) |
| TW (1) | TWI488656B (pl) |
| UY (1) | UY34796A (pl) |
| WO (1) | WO2013167233A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2565941A (en) * | 2018-11-27 | 2019-02-27 | Norton Healthcare Ltd | A process for preparing a formulation |
| CN113018443B (zh) * | 2019-12-27 | 2022-09-13 | 海南斯达制药有限公司 | 治疗呼吸系统疾病的药物组合物及其制备方法 |
| CN113952320B (zh) * | 2021-09-18 | 2022-03-18 | 健康元药业集团股份有限公司 | 一种包含妥布霉素吸入溶液的药物组件及其用途 |
| CN114796107B (zh) * | 2022-05-09 | 2024-01-09 | 西藏邦臣药业集团有限公司 | 含二磷酸烟苷的硫酸妥布霉素注射液及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508269A (en) | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
| DE60210402T2 (de) | 2001-05-18 | 2006-12-07 | Chiron Corp., Emeryville | System zur Abgabe einer Tobramycin-Formulierung |
| SI1273292T1 (en) | 2001-07-02 | 2004-12-31 | Chiesi Farmaceutici S.P.A. | Optimised formulation of tobramycin for aerosolization |
| ES2281021T3 (es) | 2003-10-15 | 2007-09-16 | Pari Pharma Gmbh | Formulacion liquida que contiene tobramicina. |
| ATE552838T1 (de) | 2003-11-14 | 2012-04-15 | Senju Pharma Co | Wässrige lösung mit aminoglykosid-antibiotikum und bromfenac |
| EP1879589A2 (en) | 2005-05-13 | 2008-01-23 | Venus Remedies Limited | Treatment and control of severe infections including cystic fibrosis |
| CN100341899C (zh) | 2005-11-01 | 2007-10-10 | 中国药科大学 | 新的壳聚糖衍生物、其制法及其用于制备眼科制剂的用途 |
| CN101129381B (zh) | 2006-08-25 | 2012-02-01 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和离子螯合剂的抗生素复方 |
| CN1927201B (zh) | 2006-08-25 | 2011-06-01 | 天津和美生物技术有限公司 | 含哌拉西林的抗生素复方 |
| CN101129383B (zh) | 2006-08-25 | 2014-04-02 | 天津和美生物技术有限公司 | 含氨基糖苷类抗生素的抗生素复方 |
| WO2008130211A1 (es) | 2007-04-20 | 2008-10-30 | Serral, S.A. De C.V. | Solución dinámica, estequiométrica de soporte y de equilibrio inducido |
| US7795316B1 (en) * | 2007-12-19 | 2010-09-14 | Alcon Research, Ltd. | Topical ophthalmic compositions containing tobramycin and dexamethasone |
| KR20130094280A (ko) | 2010-06-23 | 2013-08-23 | 알콘 리서치, 리미티드 | 토브라마이신과 덱사메타손을 함유하는 국소 안과 현탁액 |
-
2012
- 2012-05-09 GB GBGB1208080.0A patent/GB201208080D0/en not_active Ceased
-
2013
- 2013-03-19 US US13/847,265 patent/US9012416B2/en active Active
- 2013-04-18 BR BR112014027708A patent/BR112014027708A2/pt not_active Application Discontinuation
- 2013-04-18 EP EP13002039.9A patent/EP2662093B1/en active Active
- 2013-04-18 DK DK13002039.9T patent/DK2662093T3/en active
- 2013-04-18 PL PL13002039T patent/PL2662093T3/pl unknown
- 2013-04-18 PT PT130020399T patent/PT2662093E/pt unknown
- 2013-04-18 WO PCT/EP2013/001156 patent/WO2013167233A1/en active Application Filing
- 2013-05-08 UY UY0001034796A patent/UY34796A/es not_active Application Discontinuation
- 2013-05-09 TW TW102116586A patent/TWI488656B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| UY34796A (es) | 2014-11-28 |
| EP2662093A1 (en) | 2013-11-13 |
| EP2662093B1 (en) | 2015-01-14 |
| GB201208080D0 (en) | 2012-06-20 |
| DK2662093T3 (en) | 2015-02-16 |
| TWI488656B (zh) | 2015-06-21 |
| US20130303475A1 (en) | 2013-11-14 |
| BR112014027708A2 (pt) | 2017-07-18 |
| TW201350138A (zh) | 2013-12-16 |
| PT2662093E (pt) | 2015-02-17 |
| WO2013167233A1 (en) | 2013-11-14 |
| US9012416B2 (en) | 2015-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1203146A1 (en) | Antibody formulation | |
| PL2802209T3 (pl) | Preparaty do uszu | |
| GB201217441D0 (en) | Composition | |
| GB201200707D0 (en) | Composition | |
| HK1202445A1 (en) | New formulation | |
| ZA201306000B (en) | Stable formulation | |
| GB201218954D0 (en) | Composition | |
| EP2878295A4 (en) | COMPOSITION | |
| PT2662093E (pt) | Formulação de tobramicina | |
| EP2837670A4 (en) | COMPOSITION CONTAINING FLUOROBIPHENYL | |
| GB201206035D0 (en) | Composition | |
| EP2910538A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| EP2910537A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| GB201209597D0 (en) | Composition | |
| GB201208133D0 (en) | Composition | |
| HK1206989A1 (en) | Encapsulated formulation | |
| GB201219383D0 (en) | Composition | |
| GB201218195D0 (en) | Composition | |
| SI2662093T1 (sl) | Formulacija tobramicina | |
| GB201211247D0 (en) | Improved formulation | |
| GB201220595D0 (en) | Keysafe application | |
| AU2012905439A0 (en) | Formulation | |
| AU2012905410A0 (en) | Formulation | |
| GB201222922D0 (en) | Topical formulation | |
| GB201219065D0 (en) | Composition |